XOFIGO® (radium‑ 223 dichlorid) v léčbě metastatického kastračně rezistentního karcinomu prostaty
Published in the journal:
Klin Onkol 2013; 26(6): 440-441
Category:
Oncology Highlights
Zdroje
1. Nilsson S, Larsen RH, Fosså SD et al. First clinical experience with alpha‑ emitting radium‑ 223 in the treatment of skeletal metastases. Clin Cancer Res 2005; 11(12): 4451– 4459.
2. Morris P et al. Presented at: ASCO Genitourinary Cancers Symposium 2010: abstr. 211.
3. Parker C, Nilsson S, Heinrich D et al. Alpha emitter radium‑ 223 and survival in metastatic prostate cancer. N Engl J Med 2013; 369(3): 213– 223.
4. Bruland ØS, Nilsson S, Fisher DR et al. High‑linear energy transfer irradiation targeted to skeletal metastases by the alpha‑ emitter 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res 2006; 12(20 Pt 2): 6250– 6257.
5. Lewington V et al. Presented at: ASCO GU 2010: abstr. 216.
6. Morris P et al. Presented at: ASCO 2012: abstr. ID #TPS4694.
7. Parker C et al. Presented at: ESMO 2012: poster 898PD.
Štítky
Paediatric clinical oncology Surgery Clinical oncologyČlánok vyšiel v časopise
Clinical Oncology
2013 Číslo 6
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Syndrome of Vena Cava Obstruction in Oncology
- Is Preoperative Bone Scintigraphy in Early Stage of Breast Cancer T1N0 Indicated and Meaningful?
- Smoking and Breast Cancer
- The Assessment of Quality of Life of Patients at Oncological Clinic – Pilot Study